Linked from

The 178 pages that link to Pharmacokinetics, each with the reason it gives.

• PharmacogenomicsRelated: Genetic differences in these processes help explain variation in drug exposure.

• Drug discoveryRelated: A potent compound may fail if it cannot reach and remain at its site of action.

• Herbal medicineRelated: It explains why an herb’s effects depend on absorption and metabolism.

• Intravenous therapyRelated: Venous delivery bypasses absorption barriers and changes how quickly a drug reaches circulation.

• AntivenomRelated: Antivenom distribution and clearance affect how long toxin neutralization lasts.

• Henderson–Hasselbalch equationRelated: Ionization estimates based on pH and pKa help explain drug solubility and membrane passage.

• Drug deliveryRelated: These processes determine how delivery choices shape a drug’s concentration over time.

• Therapeutic indexRelated: These processes determine how administered doses translate into exposure and toxicity.

• Partition coefficientRelated: Partitioning between blood, tissues, and membranes shapes drug distribution.

• AmoxicillinRelated: Oral absorption and renal elimination shape amoxicillin dosing.

• Forensic toxicologyRelated: It explains why a measured concentration depends on dose, timing, and biological change.

• Mass balanceRelated: Compartment models balance drug amounts as they move and transform in the body.

• Nuclear medicineRelated: Tracer movement through the body shapes the meaning of nuclear images.

• Medicinal chemistryRelated: Exposure over time depends on molecular properties that medicinal chemists can alter.

• Physical dependenceRelated: A substance's duration and clearance influence exposure patterns and the timing of withdrawal.

• Exponential decayRelated: First-order drug elimination makes concentration fall exponentially over time.

• PharmacyRelated: These processes shape dosing decisions and the timing of medicine effects.

• AmphetamineRelated: Absorption and elimination shape how quickly amphetamine acts and how long its effects last.

• Generic drugRelated: These measurements establish whether the generic produces comparable drug exposure.

• Opioid analgesicsRelated: These processes help determine how quickly an opioid acts and how long it lasts.

• Parameter estimationRelated: Model parameters such as clearance are estimated from concentration measurements.

• Chelation therapyRelated: A chelator’s movement through tissues affects which metal pools it can reach.

• Photodynamic therapyRelated: Photosensitizer distribution and clearance shape treatment timing and unwanted light sensitivity.

• PralidoximeRelated: Pralidoxime's distribution and clearance shape dosing and access to affected tissues.

• RadiopharmaceuticalRelated: A carrier's pharmacokinetics shape where radioactivity travels and how quickly it clears.

• AzithromycinRelated: Its tissue distribution and long elimination half-life shape azithromycin regimens.

• Active pharmaceutical ingredientRelated: It explains how much API reaches its targets and for how long.

• LSDRelated: LSD’s slow clearance helps account for its long-lasting effects.

• BiosimilarRelated: Comparative studies assess whether the products behave similarly in the body.

• Efflux pumpRelated: Efflux transporters affect drug absorption and tissue exposure in the body.

• EndocrinologyRelated: Drug handling shapes dosing schedules for many endocrine therapies.

• GLP-1 receptor agonistRelated: Long-acting formulations depend on pharmacokinetic designs that permit weekly or daily dosing.

• MethylphenidateRelated: Absorption and elimination help explain why formulations produce different durations of effect.

• SertralineRelated: Absorption and metabolism shape sertraline’s dosing and duration.

• Tranexamic acidRelated: Its renal elimination and route-dependent exposure guide safe tranexamic acid dosing.

• VenlafaxineRelated: Venlafaxine's metabolism and short elimination half-life help explain dosing and withdrawal considerations.

• ErythromycinRelated: Erythromycin’s absorption and metabolism shape its dosing and interaction profile.

• LevothyroxineRelated: Levothyroxine's slow elimination helps explain its long dosing interval and delayed response to changes.

• Psychiatric medicationRelated: Drug concentration over time helps determine dosing schedules and delayed or prolonged effects.

• PsychopharmacologyRelated: Drug concentration over time helps determine onset, duration, and dosing.

• Treatment-resistant depressionRelated: Drug interactions or rapid metabolism can reduce exposure and mimic an ineffective treatment.

• AntidoteRelated: A poison's movement through the body shapes whether an antidote can reach it in time.

• Biologic therapyRelated: Large biological molecules have distinctive distribution and clearance patterns that shape dosing.

• Drug developmentRelated: These measurements help determine dosing and interpret exposure in development studies.

• CetirizineRelated: Cetirizine’s absorption and renal elimination shape its dosing and duration of action.

• PharmacotherapyRelated: These processes determine drug concentrations over time and inform dosing.

• ProgestinRelated: Differences in these properties help explain why progestins have distinct doses and dosing schedules.

• Psychoactive drugRelated: Absorption and clearance help determine how quickly effects begin and how long they last.

• SpironolactoneRelated: Its active metabolites and relatively slow onset help explain dosing and effect timing.

• Antifungal drugRelated: Drug exposure at the infected tissue affects whether an antifungal regimen can work.